Correlation Between Erasca and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Erasca and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Erasca and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Erasca Inc and Inhibrx, you can compare the effects of market volatilities on Erasca and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Erasca with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Erasca and Inhibrx.
Diversification Opportunities for Erasca and Inhibrx
Weak diversification
The 3 months correlation between Erasca and Inhibrx is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Erasca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Erasca Inc are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Erasca i.e., Erasca and Inhibrx go up and down completely randomly.
Pair Corralation between Erasca and Inhibrx
Given the investment horizon of 90 days Erasca Inc is expected to under-perform the Inhibrx. In addition to that, Erasca is 1.58 times more volatile than Inhibrx. It trades about -0.16 of its total potential returns per unit of risk. Inhibrx is currently generating about 0.0 per unit of volatility. If you would invest 1,512 in Inhibrx on October 12, 2024 and sell it today you would lose (14.00) from holding Inhibrx or give up 0.93% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Erasca Inc vs. Inhibrx
Performance |
Timeline |
Erasca Inc |
Inhibrx |
Erasca and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Erasca and Inhibrx
The main advantage of trading using opposite Erasca and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Erasca position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Erasca vs. Century Therapeutics | Erasca vs. Keros Therapeutics | Erasca vs. Monte Rosa Therapeutics | Erasca vs. Design Therapeutics |
Inhibrx vs. Ginkgo Bioworks Holdings | Inhibrx vs. CureVac NV | Inhibrx vs. Iovance Biotherapeutics | Inhibrx vs. Krystal Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |